Cargando…

Sumoylation of CCAAT‐enhancer‐binding protein α inhibits lung differentiation in Bronchopulmonary Dysplasia model rats

Bronchopulmonary dysplasia (BPD) is a major cause of mortality and morbidity in premature infants, characterized by alveolar simplification, surfactant deficiency, and respiratory distress. In the present study, we have investigated the functional roles of sumoylated CCAAT/enhancer binding protein a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yue, Chen, Xiaoqing, Mi, Lanlan, Wang, Qiuxia, Zhu, Haitao, Ju, Huimin, Lu, Hongyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299724/ https://www.ncbi.nlm.nih.gov/pubmed/32363643 http://dx.doi.org/10.1111/jcmm.15310

Ejemplares similares

Tissue-Resident Type 2 Innate Lymphoid Cells Arrest Alveolarization in Bronchopulmonary Dysplasia
por: Mi, Lanlan, et al.
Publicado: (2020)

Sumoylation of CCAAT/enhancer-binding protein α is implicated in hematopoietic stem/progenitor cell development through regulating runx1 in zebrafish
por: Yuan, Hao, et al.
Publicado: (2015)

Dynamic Changes of NCR(−) Type 3 Innate Lymphoid Cells and Their Role in Mice with Bronchopulmonary Dysplasia
por: Cai, Jiayu, et al.
Publicado: (2022)

IL‐33‐ST2 pathway regulates AECII transdifferentiation by targeting alveolar macrophage in a bronchopulmonary dysplasia mouse model
por: Zhu, Yue, et al.
Publicado: (2022)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Differential effects of sumoylation on the activities of CCAAT enhancer binding protein alpha (C/EBPα) p42 versus p30 may contribute in part, to aberrant C/EBPα activity in acute leukemias
por: Hankey, William, et al.
Publicado: (2011)

Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma
por: Pan, Zemin, et al.
Publicado: (2014)

Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia
por: Zhang, Zhaohua, et al.
Publicado: (2018)

CCAAT/enhancer-binding protein α is required for hepatic outgrowth via the p53 pathway in zebrafish
por: Yuan, Hao, et al.
Publicado: (2015)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Mesenchymal stromal/stem cells and bronchopulmonary dysplasia
por: Zhang, Shuqing, et al.
Publicado: (2023)

Biological roles of CCAAT/Enhancer-binding protein delta during inflammation
por: Ko, Chiung-Yuan, et al.
Publicado: (2015)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Hospital management of severe bronchopulmonary dysplasia
por: Moretti, Corrado, et al.
Publicado: (2015)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

The rate and pattern of bronchopulmonary dysplasia in Kuwait
por: Al-Essa, Mazen, et al.
Publicado: (2004)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

New Pharmacologic Approaches to Bronchopulmonary Dysplasia
por: Roberts, Katelyn, et al.
Publicado: (2021)

An Update on the Prevention and Management of Bronchopulmonary Dysplasia
por: Hennelly, Marissa, et al.
Publicado: (2021)

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
por: Sakaria, Rishika P., et al.
Publicado: (2022)

Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
por: Nelin, Leif D., et al.
Publicado: (2022)

Development and Disorders of the Airway in Bronchopulmonary Dysplasia
por: Bush, Douglas, et al.
Publicado: (2023)

Editorial: Bronchopulmonary dysplasia: latest advances
por: Perveen, Shahana, et al.
Publicado: (2023)

CCAAT/Enhancer Binding Protein β inhibits myogenic differentiation via ID3
por: AlSudais, Hamood, et al.
Publicado: (2018)

A nomogram for predicting the risk of Bronchopulmonary dysplasia in premature infants
por: Shen, Xian, et al.
Publicado: (2023)

Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Postnatal Risk Factors
por: Ding, Li, et al.
Publicado: (2020)

Lipopolysaccharide Induces Up-Regulation of TGF-α through HDAC2 in a Rat Model of Bronchopulmonary Dysplasia
por: Ni, Wensi, et al.
Publicado: (2014)

Effects of C/EBPα overexpression on alveolar epithelial type II cell proliferation, apoptosis and surfactant protein-C expression after exposure to hyperoxia
por: Lu, Hongyan, et al.
Publicado: (2019)

Effect of early vitamin A supplementation on bronchopulmonary dysplasia in premature infants
por: Huang, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h4jkjctcu8ludfoar1cq73dldd